Konstantinos Votanopoulos to Extremities
This is a "connection" page, showing publications Konstantinos Votanopoulos has written about Extremities.
Connection Strength
1.522
-
Chouliaras K, Patel N, Senehi R, Ethun CG, Poultsides G, Grignol V, Gamblin TC, Roggin KK, Fields RC, D'Agostino R, Levine EA, Cardona K, Votanopoulos K. Impact of resection margin on outcomes in high-grade soft tissue sarcomas of the extremity-A USSC analysis. J Surg Oncol. 2021 Feb; 123(2):479-488.
Score: 0.727
-
Strong EA, Park SH, Ethun CG, Chow B, King D, Bedi M, Charlson J, Mogal H, Tsai S, Christians K, Tran TB, Poultsides G, Grignol V, Howard JH, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Cullinan D, Fields RC, Gamblin TC, Cardona K, Clarke CN. High neutrophil-lymphocyte ratio is not independently associated with worse survival or recurrence in patients with extremity soft tissue sarcoma. Surgery. 2020 10; 168(4):760-767.
Score: 0.178
-
Shelby RD, Suarez-Kelly LP, Yu PY, Hughes TM, Ethun CG, Tran TB, Poultsides G, King DM, Bedi M, Mogal H, Clarke C, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick BA, Fields RC, Pollock RE, Howard JH, Cardona K, Grignol V. Neoadjuvant radiation improves margin-negative resection rates in extremity sarcoma but not survival. J Surg Oncol. 2020 Jun; 121(8):1249-1258.
Score: 0.174
-
Zaidi MY, Ethun CG, Tran TB, Poultsides G, Grignol VP, Howard JH, Bedi M, Mogal H, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick B, Fields RC, Oskouei S, Reimer N, Monson D, Maithel SK, Cardona K. Assessing the Role of Neoadjuvant Chemotherapy in Primary High-Risk Truncal/Extremity Soft Tissue Sarcomas: An Analysis of the Multi-institutional U.S. Sarcoma Collaborative. Ann Surg Oncol. 2019 Oct; 26(11):3542-3549.
Score: 0.166
-
Johnson AC, Ethun CG, Liu Y, Lopez-Aguiar AG, Tran TB, Poultsides G, Grignol V, Howard JH, Bedi M, Gamblin TC, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Cullinan D, Fields RC, Delman KA, Wood WC, Cardona K, Maithel SK. Studying a Rare Disease Using Multi-Institutional Research Collaborations vs Big Data: Where Lies the Truth? J Am Coll Surg. 2018 09; 227(3):357-366.e3.
Score: 0.154
-
Squires MH, Ethun CG, Suarez-Kelly LP, Yu PY, Hughes TM, Shelby RD, Tran TB, Poultsides G, Charlson J, Gamblin TC, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick BA, Fields RC, Pollock RE, Grignol V, Cardona K, Howard JH. Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas. J Surg Res. 2020 01; 245:577-586.
Score: 0.042
-
Zaidi MY, Ethun CG, Liu Y, Poultsides G, Howard JH, Mogal H, Tseng J, Votanopoulos K, Fields RC, Cardona K. The impact of unplanned excisions of truncal/extremity soft tissue sarcomas: A multi-institutional propensity score analysis from the US Sarcoma Collaborative. J Surg Oncol. 2019 Sep; 120(3):332-339.
Score: 0.041
-
Johnson AC, Ethun CG, Liu Y, Poultsides G, Howard JH, Bedi M, Charlson J, Tseng J, Roggin KK, Votanopoulos K, Cullinan D, Fields RC, Maithel SK, Cardona K. A novel, simplified, externally validated staging system for truncal/extremity soft tissue sarcomas: An analysis of the US Sarcoma Collaborative database. J Surg Oncol. 2018 Dec; 118(7):1135-1141.
Score: 0.039